PMID- 33946176 OWN - NLM STAT- MEDLINE DCOM- 20210526 LR - 20210526 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 22 IP - 9 DP - 2021 Apr 30 TI - MitoQ Is Able to Modulate Apoptosis and Inflammation. LID - 10.3390/ijms22094753 [doi] LID - 4753 AB - Mitoquinone (MitoQ) is a mitochondrial reactive oxygen species scavenger that is characterized by high bioavailability. Prior studies have demonstrated its neuroprotective potential. Indeed, the release of reactive oxygen species due to damage to mitochondrial components plays a pivotal role in the pathogenesis of several neurodegenerative diseases. The present study aimed to examine the impact of the inflammation platform activation on the neuronal cell line (DAOY) treated with specific inflammatory stimuli and whether MitoQ addition can modulate these deregulations. DAOY cells were pre-treated with MitoQ and then stimulated by a blockade of the cholesterol pathway, also called mevalonate pathway, using a statin, mimicking cholesterol deregulation, a common parameter present in some neurodegenerative and autoinflammatory diseases. To verify the role played by MitoQ, we examined the expression of genes involved in the inflammation mechanism and the mitochondrial activity at different time points. In this experimental design, MitoQ showed a protective effect against the blockade of the mevalonate pathway in a short period (12 h) but did not persist for a long time (24 and 48 h). The results obtained highlight the anti-inflammatory properties of MitoQ and open the question about its application as an effective adjuvant for the treatment of the autoinflammatory disease characterized by a cholesterol deregulation pathway that involves mitochondrial homeostasis. FAU - Piscianz, Elisa AU - Piscianz E AUID- ORCID: 0000-0001-7374-1684 AD - Hygiene and Public Health Unit (ASUGI), 34129 Trieste, Italy. FAU - Tesser, Alessandra AU - Tesser A AUID- ORCID: 0000-0001-6267-3794 AD - Department of Pediatrics, Institute for Maternal and Child Health-IRCCS Burlo Garofolo, 34137 Trieste, Italy. FAU - Rimondi, Erika AU - Rimondi E AD - Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy. FAU - Melloni, Elisabetta AU - Melloni E AUID- ORCID: 0000-0002-7829-0824 AD - Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy. FAU - Celeghini, Claudio AU - Celeghini C AD - Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy. FAU - Marcuzzi, Annalisa AU - Marcuzzi A AD - Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy. LA - eng PT - Journal Article DEP - 20210430 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Free Radical Scavengers) RN - 0 (Organophosphorus Compounds) RN - 0 (Reactive Oxygen Species) RN - 1339-63-5 (Ubiquinone) RN - 47BYS17IY0 (mitoquinone) SB - IM MH - Anti-Inflammatory Agents/*pharmacology MH - Apoptosis/*drug effects MH - Cell Line MH - Free Radical Scavengers/*pharmacology MH - Humans MH - Inflammation/*drug therapy/metabolism MH - Mitochondria/metabolism MH - Neurons/cytology/drug effects/metabolism MH - Organophosphorus Compounds/*pharmacology MH - Reactive Oxygen Species/metabolism MH - Ubiquinone/*analogs & derivatives/pharmacology PMC - PMC8124358 OTO - NOTNLM OT - autophagy OT - cholesterol OT - cytokines OT - inflammation OT - mitochondria COIS- The authors declare no conflict of interest. EDAT- 2021/05/06 06:00 MHDA- 2021/05/27 06:00 PMCR- 2021/04/30 CRDT- 2021/05/05 01:01 PHST- 2021/03/30 00:00 [received] PHST- 2021/04/25 00:00 [revised] PHST- 2021/04/27 00:00 [accepted] PHST- 2021/05/05 01:01 [entrez] PHST- 2021/05/06 06:00 [pubmed] PHST- 2021/05/27 06:00 [medline] PHST- 2021/04/30 00:00 [pmc-release] AID - ijms22094753 [pii] AID - ijms-22-04753 [pii] AID - 10.3390/ijms22094753 [doi] PST - epublish SO - Int J Mol Sci. 2021 Apr 30;22(9):4753. doi: 10.3390/ijms22094753.